🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of acetaminophen, asserting the corporations hid potential risks that the pain reliever posed to pediatric neurological development.

The lawsuit arrives a month after President Donald Trump promoted an unsubstantiated connection between using acetaminophen - also known as acetaminophen - throughout gestation and autism in children.

The attorney general is filing suit against the pharmaceutical giant, which previously sold the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "deceived the public by profiting off of discomfort and marketing drugs without regard for the dangers."

The company says there is insufficient reliable data connecting acetaminophen to autism.

"These manufacturers lied for decades, deliberately risking countless individuals to increase profits," Paxton, from the Republican party, stated.

Kenvue stated officially that it was "very worried by the spread of false claims on the security of paracetamol and the possible consequences that could have on the welfare of women and children in America."

On its website, the company also mentioned it had "regularly reviewed the pertinent research and there is lacking reliable evidence that shows a verified association between consuming paracetamol and autism."

Organizations representing doctors and health professionals share this view.

The American College of Obstetricians and Gynecologists has stated paracetamol - the main ingredient in Tylenol - is a restricted selection for expectant mothers to manage discomfort and elevated temperature, which can pose major wellness concerns if not addressed.

"In over twenty years of research on the use of acetaminophen in gestation, not a single reputable study has successfully concluded that the consumption of paracetamol in any period of pregnancy causes brain development issues in young ones," the organization said.

This legal action mentions latest statements from the former administration in arguing the drug is potentially dangerous.

In recent weeks, Trump caused concern from health experts when he advised expectant mothers to "resist strongly" not to use acetaminophen when ill.

Federal regulators then published an announcement that doctors should consider limiting the usage of acetaminophen, while also stating that "a proven link" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had promised in spring to conduct "comprehensive study program" that would establish the cause of autism spectrum disorder in a limited time.

But specialists advised that discovering a sole reason of autism - considered by experts to be the consequence of a complex mix of genetic and surrounding conditions - would not be simple.

Autism is a form of permanent neurological difference and disability that influences how people encounter and interact with the surroundings, and is identified using medical professional evaluations.

In his legal document, Paxton - who supports Trump who is campaigning for the Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The case attempts to require the corporations "destroy any commercial messaging" that asserts Tylenol is secure for women during pregnancy.

The court case echoes the concerns of a assembly of guardians of young ones with autism and ADHD who took legal action against the makers of Tylenol in recently.

A federal judge threw out the lawsuit, declaring studies from the parents' expert witnesses was lacking definitive proof.